Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer. (Q42719159)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488744%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488744%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

1 reference

Katja Kiseljak-Vassiliades

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488744%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Andrew J Weickhardt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488744%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Micol S Rothman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488744%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Smita Salian-Mehta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488744%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Ana B Oton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488744%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Robert C Doebele

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488744%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Margaret E Wierman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488744%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

D Ross Camidge

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488744%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

language of work or name

English

0 references

publication date

4 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488744%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488744%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488744%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488744%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

5302-5309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22488744%20AND%20SRC:MED&resulttype=core&format=json

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Crizotinib--latest champion in the cancer wars?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Testosterone Levels and Quality of Life in Diverse Male Patients With Cancers Unrelated to Androgens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Clinical outcomes and contributors to weight loss in a cancer cachexia clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Testicular function following chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Identification of late-onset hypogonadism in middle-aged and elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

The relationship of gonadal activity and chemotherapy-induced gonadal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

The receptor encoded by the human C-MET oncogene is expressed in testicular tissue and on human spermatozoa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Characterization of the expression of the ALK receptor tyrosine kinase in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Anaplastic lymphoma kinase: signalling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Expression of hepatocyte growth factor and its receptor c-Met in human pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Hepatocyte growth factor/scatter factor facilitates migration of GN-11 immortalized LHRH neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Associations among hypogonadism, C-reactive protein, symptom burden, and survival in male cancer patients with cachexia: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Low serum testosterone and mortality in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Low free testosterone levels are associated with prevalence and incidence of depressive symptoms in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

The pathogenesis of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450

The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27450